Summary: Natural antibodies are unique self molecules endowed with both suppressive and activating functions on various cells of the immune system and are recognized as a fundamental link between the adaptive and innate immune system. Here, we examine the role of natural antibodies, using polyclonal immunoglobulins (Ig), as a promoter of T-cell reconstitution in a context of lymphopenia. We have established a mouse model to mimic immunologic recovery in adult patients with severe hypothymic function subjected to autologous hematopoietic precursor cell transplantation. Thymectomized mice were transplanted and treated with low doses of Ig or its Fab or Fc fragments. The animals displayed, during early phases of Ig treatment, a significant increase of T-cell reconstitution displaying a naive CD4 + phenotype. In addition, the Igtreated animals exhibited an increase dilution of single-joint T-cell receptor excision circles (sjTRECs) in peripheral blood, suggesting an early increase in proliferation of T cells stimulated by the natural antibodies. These results unveil a novel and considerable effect of intravenous Ig treatment in situations of severe lymphopenia as a stimulator of proliferation of peripheral naive T cells, possibly protecting diverse immune repertoires.
D
uring immune reconstitution, the regeneration of T cells depends on a tuned balance between thymopoiesis and peripheral homeostatic proliferation. Thymic function is commonly compromised in adults, because it declines with increasing age. 1 Moreover, in adult patients with immunologic neoplasias under chemotherapy, radiotherapy, or corticotherapy, thymus involution is even accelerated. In this context, most T-cell immune reconstitution relies upon peripheral expansion mechanisms driven by cytokine and antigen stimulation and occurs mainly within the cellular memory compartments. 2, 3 Recently, interesting results have implicated interleukin (IL)-7 in promoting the expansion of naive T cells in the setting of immune reconstitution. 4, 5 Besides IL-7, other modulators of this process act on T and B lymphocytes, macrophages, and natural killer cells by activating proliferation and stimulating their activities. During immune reconstitution, the inevitable expansion of a limited number of T-cell receptor (TCR) clones leads to contraction and skewing of T-cell repertoire diversity, with obvious disadvantages for broad immune competence and possibly survival. 6 Although the maintenance of a memory T-cell reservoir is certainly beneficial for a rapid response against known antigens, diversity is also critical for immune competence. [6] [7] [8] In lymphopenia, as during immune reconstitution, molecules with a role in TCR diversification and selection may be fundamental as promoters of a broad representation of TCR clones even during activation and proliferation of peripheral naive T cells. Polyclonal immunoglobulin (Ig) is a unique self molecule known as a key immune regulator possibly involved in these processes. Its therapeutic use varies from immunomodulator in situations of severe inflammation, 9 such as sepsis 10 and autoimmunity, [11] [12] [13] to a substitution treatment for patients with primary and secondary hypogammaglobulinemia [14] [15] [16] and also applied in the area of solid organ transplantation. 17 Ig has a vast effect on the immune system, both innate and adaptive. 11, 12, 18, 19 In addition, its effect seems to be dual and dose-dependent. For instance, in supra-physiologic doses, Ig inhibits the maturation of dendritic cells and consequently antigenic presentation and T-cell proliferation. 20 In contrast, at physiologic doses, Ig is able to stimulate the maturation of dendritic cells through stimulation via the CD40 receptor. 18, 21 The mechanisms of action of Ig on the T-cell compartment may be direct, through the recognition of Fab portions by the TCRs, and/or indirectly through the activation of other immune cells, responsive to the Fab or Fc fragments. T cells may express Fcg receptors depending on the level of activation. 22 Apparently, mature resting T cells express very low or undetectable amounts of Fc receptors, but after activation, T cells may express them. 22 However, the effect of Ig molecule in stimulating and/or modulating T-cell homeostasis has not yet been fully understood. Recent studies point to a new mechanism of interaction between T cells and the Ig molecule, implicating the expansion of regulatory T cells (Treg) in the setting of autoimmunity.
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Here we present novel data on the effect of polyclonal Ig on the peripheral compartment of the immune system during lymphopenia, promoting T-cell reconstitution and protecting the naive phenotype. The model described here mimics the process of immune reconstitution after myeloablative treatment rescued by autologous stem cell transplantation (ASCT) in human adults. Cellular and molecular results show that treatment with Ig and its fragments increases naive T-cell survival and/or proliferation immediately after myeloablative treatments.
MATERIALS AND METHODS

Mice
Mice were bred and maintained under specific pathogen-free conditions at the Instituto Gulbenkian de Cieˆncia animal facility. Experimental protocols were approved by the institutional ethics committee and the Portuguese veterinary general division. At 3 to 4 weeks of age, Balb/c female mice were anesthetized (ketamine and xylazine, 12%/8% vol/vol), and suction thymectomy was performed through sternal incision. Complete thymectomy was verified by necropsies. These mice constitute the thymectomized recipients for the ASCT experiments described below.
Four groups of 6 to 8 weeks old thymectomized mice (average number of mice/group was 6) were independently set up, and subjected to a lethal dose of radiation (7 Gy) followed by ASCT. A group of thymectomized mice, agematched and sex-matched, and not subjected to radiation or ASCT was used for comparison. In each group of mice, the set-up of the groups and the experiments were, at least, performed 2 or more times independently. A control experiment was performed to assess the extent of myeloablation by irradiation. We verified that all the mice that were irradiated but not transplanted (n = 6), died during the first 2 weeks after irradiation, secondary to myeloablation (data not shown).
Autologous Stem Cell Transplantation
Thymus-intact Balb/c female mice 6 to 8 weeks old were used as donors of hematopoietic progenitor cells. Mice were injected subcutaneously with 7.5 mg of granulocyte colony-stimulating factor (Neupogenc, Filgrastim) for 4 consecutive days. On the fifth day, the mononuclear cells were isolated by a Ficoll/Hypaque gradient from total peripheral blood. Cellular concentration was determined in a Neubauer-counting chamber. In all, 2 Â 10 5 mononuclear cells were injected intravenously 26 per mouse, through the retro-orbital vein. A control experiment was performed to assess the extent of myeloablation by irradiation. We demonstrated that all the mice irradiated but not transplanted (n=6) died during the two first weeks after the irradiation, secondary to myeloablation (data not shown).
Treatment With Ig and Fragments
Ig treatments were started on the day of ASCT. Equal concentrations of mouse IgG molecule or its Fab or Fc preparations were weekly (250 mg/wk) administered by intraperitoneal injections. Dosage was calculated by taking into account the standard dose of intravenous Ig (IvIg) used for humans in the case of hypogammaglobulinemia (400 mg/kg of body weight every 4 wk).
14 IgG, Fab, and Fc preparations were purchased from Rockland (IgG) and Jackson ImmunoResearch. The purity of the preparations was tested and confirmed through sodium dodecyl sulfate-polyacrylamide gel electrophoresis (data not shown). The control group was injected weekly with phosphatebuffered saline 1 Â (saline treatment) intraperitoneally. Control groups testing no diverse proteins were included in earlier studies 19 and showed similar results. All animal procedures were performed in accordance with the protocols approved by the local Committee for Animal Experiments.
Flow Cytometry Analysis
After transplantation, lymphocyte subtypes were weekly analyzed by flow cytometry. Immunophenotyping analysis by flow cytometry started 2 weeks after ASCT and continued for 13 weeks.
Erythrocytes were lysed using a standard NH 4 
Molecular Analysis: TCR Excision Circle Assays
DNA was extracted from blood using Citogene Blood Kit (Citomed) and following manufacturer's instructions. DNA content was quantified using a Nanodrop spectrophotometer. Single-joint TCR excision circle (sjTREC) assays were used for measuring the magnitude of the cellular proliferation at the periphery. 27, 28 The molecular strategy for sjTREC measurement is based on an earlier study 29 and used a TaqMan probe-based chemistry. The polymerase chain reaction (PCR) was performed on a 20 mL reaction containing 1 Â TaqMan Universal PCR Master mix (Applied Biosystems), 300 nM of forward and reverse primers, 200 nM of probe, and 100 ng of isolated DNA. PCR conditions were 951C for 10 minutes followed by 50 cycles of 951C for 15 seconds and 601C for 1 minute using an ABI Prism 7900 HT system (Perkin Elmer). Nontemplate reactions were included to monitor for contamination. The amplification plots of the PCR reaction were used to determine the threshold cycle (Ct).
Standards were prepared with cloned products of the sequence of interest. For each TREC and Ca-DNA plasmid, a standard was obtained by cloning the TREC or Ca-PCR product into a pJET cloning vector (Fermentas). After amplification in DH5a Escherichia coli, and validation of the insertion by PCR, plasmid DNA was purified with Qiagen Miniprep kit (Qiagen) following the manufacturer's instructions. Before their use, the inserts were confirmed by DNA sequencing using the pJET' primers. The concentration of the plasmid DNA stock was determined by the limiting dilutions method. Real-time PCR for Ca was performed to normalize the cell number in each sample. All samples and standards were tested in duplicate and their Ct value was determined by the Sequence Detector software v3.0 (Applied Biosystems).
SjTREC levels normalized by sjTRECs/2 Â 10 5 copies of Ca fragment, equaling sjTRECs/10 5 peripheral blood mononuclear cells (PBMCs), were quantified weekly up to the 10th week after transplant. Peripheral blood from thymus-intact Balb/c mice was examined between 6 and 48 weeks of age (n = 14 samples). RAG-1 À / À mice in the Balb/c background were used as negative controls.
Statistical Analysis
The Shapiro-Wilk test was used to test the normality of data. When this condition held, Student t test was conducted to compare the differences between the mean values of Ig-treated and control groups. When the normality assumption was violated, the Wilcoxon rank-sum test (Mann-Whitney test) was performed.
The reconstitution of CD4 and CD8 T-cell counts over time was compared between the Ig-treated and control groups using the generalized least square (GLS) approach through the GLS function in the nlme library R (version 2.7.2), a methodology proposed by Pinheiro and Bates. 30 Correlation between decreasing levels of sjTRECs/10 5 PBMCs with age was confirmed by the Pearson correlation coefficient.
RESULTS
Immune Reconstitution Model and Cellular Characterization of the Grafts
We developed an animal model to study the modulation of immune reconstitution after ASCT in human adults with a compromised thymic function. This situation was mimicked by severe myeloablative conditioning of thymectomized mice followed by syngeneic autologous transplantation of hematopoietic precursor-enriched peripheral blood. In this model, we tested whether periodic injections with low concentrations of polyclonal Ig or its fragments were able to improve T-cell reconstitution in a situation of severe lymphopenia. 
Reconstitution of CD4
+ and CD8 + T Cells After ASCT in Ig-treated Mice
Before testing the effect of the Ig molecule on the reconstitution of T cells after ASCT in thymectomized mice, we established the independent effect of thymectomy on the number of CD4 + and CD8 + T cells, and compared it with the subpopulations of T cells in thymus-intact, agematched and sex-matched syngeneic mice. Analyses were performed at 9 weeks after thymectomy (mice were 12 to 13 wk old).
Athymic mice remained significantly lymphopenic when compared with thymus-intact, age-matched and sexmatched, syngeneic mice median/mean of 117/138 versus 555/553 CD4 + T cells/mL of blood, respectively (P = 0.00023, Student t test), and 46/60 versus 165/165 CD8+ T cells/mL of blood respectively, as shown in Table 1 (P = 0.028, Wilcoxon test).
When athymic mice were subjected to ASCT, the state of lymphopenia can be less severe than that induced by thymectomy alone as athymic mice subjected to myeloablative therapy and ASCT, achieved, at 9 to 10 weeks after ASCT, a median of 152 and 49 of CD4 + and CD8 + T cells/ mL, respectively in peripheral blood. These values were higher than that found in nontransplanted thymectomized mice. This result is likely to be due to peripheral T-cell proliferation triggered by the transplant itself, as it has been shown that cells from the graft start to proliferate soon after transplant in the recipient's peripheral compartment 31 ; some of them without altering their naive markers. 32, 33 However, lymphopenia remained during the entire follow-up time in this model, when compared with lymphocyte counts exhibited by thymus-intact age-matched and sex-matched mice (Table 1) . Therefore, we designed this lymphopenic mouse model to examine the effects of Ig in promoting the process of immune reconstitution after ASCT. CD4 + and CD8 + T cells in thymus-intact mice, thymectomized Balb/c mice not subjected to radiotherapy or autologous stem cell transplant and thymectomized Balb/c mice subjected to radiotherapy and autologous stem cell transplant. All mice are 12 wk old (transplanted mice are 6 weeks after the transplant). Groups comprise 4 to 5 mice.
*Not being subjected to radiotherapy or transplant. wBeing subjected to radiotherapy and transplant.
The effect of treatment with polyclonal Ig or its fragments on the longitudinal reconstitution of CD4 + T cells after transplant is shown in Figure 2A . Ig-treated mice attained significantly higher numbers of CD4 + T cells at earlier time points after ASCT, when compared with control mice (P = 0.038 at 2 wk after ASCT, Wilcoxon test, see legend of Fig. 2) . Later, Ig-treated individuals reached an equilibrium state, though never achieving the numbers exhibited by age-matched and sex-matched syngeneic, thymus-intact nontransplanted mice (median/ mean of 145/177 vs. 555/553 CD4 + T cells/mL of blood, respectively, Fig. 2A and Table 1 , P = 2.13e-05, Student t test for mean comparisons).
Non-Ig-treated control mice, although receiving a similar number of cells in the grafts (eg, at the time of transplant, 1.88 Â 10 4 CD4 + T cells were injected in each mouse), showed a much slower reconstitution process when compared with Ig-treated mice ( Fig. 2A) . Specifically, at 2 weeks after ASCT, non-Ig-treated mice had a median of 96/mL CD4 + circulating T cells and Ig-treated reconstituted around 2.5 times more CD4 + T cells. By the end of the follow-up, control mice recovered CD4 + T-cell values similar to age-matched and sex-matched (13 to 16 wk), nontransplanted thymectomized mice (median/mean of 101/111 vs. 117/138 CD4 + T cells/mL of blood; P = 0.59, Student t test for mean comparisons) ( Table 1 and Fig. 2A ), indicating that in athymic mice, the peripheral expansion of T cells subsequent to transplantation was insufficient to overcome the lymphopenia induced by thymectomy. Despite the expansion, which is induced by ASCT per se, the total number of regenerated CD4 + T cells in thymectomized hosts 10 weeks after transplant was significantly lower than in age-matched and sex-matched thymus-bearing mice not subjected to ASCT (P = 5.34e-7, Student t test).
The pattern of CD8 + T-cell reconstitution was different from what occurs in the CD4 + T-cell compartment described above. The recovery of CD8 + T cells was progressive and similar between Ig-treated and control groups during the first few weeks after transplant (Fig. 2B) . However, after 8 weeks, treated groups significantly increased their CD8 + T-cell numbers. In contrast, the control group did not accelerate CD8 + cell recovery over time, as depicted in Figure 2B . Although the CD8 + T-cell compartments expanded in the studied groups, mice never reached normal values. At the end of the follow-up, control mice recovered a median/mean value of 40/37 CD8 + T cells/mL of blood (similar to those of nontransplanted thymectomized mice (46/65 CD8 + T cells/mL of blood; P = 0.23, Student t test). These values were significantly inferior to those observed with Ig-treated mice (P = 0.003, Student t test).
A profile analysis accounting for time was performed to describe the continuous recuperation of CD4 + and 
Reconstitution of Naive and Memory CD4 + T-cell Subpopulations in Ig-treated Mice
CD4
+ T-cell subpopulations were analyzed for their naive (defined as CD4 + CD62L + ) and stringent memory (defined as CD4 + CD44hi + ) content. Figure 3A shows that in mice treated with Ig, there was a significant increase in naive CD4 + T-cell numbers during the first weeks after ASCT when compared with the control group (at 2 and 4 wk, P = 2.08e-5 and P = 0.0034, respectively, Student t test), suggesting a direct effect of Igs on the maintenance of a naive CD4 + peripheral T-cell compartment. In contrast, in the control group, memory CD4 + T cells predominated in the early phase after ASCT. By the end of the follow-up (10 wk after ASCT) there was, however, an increase in the number of naive CD4 + T cells in the control group. This suggests that a proliferation of naive T cells without the acquisition of a memory phenotype also occurred in mice undergoing myeloablative treatment with hematopoietic salvage (ASCT) without any external treatment. Importantly, this phenomenon occurred much earlier in groups under Ig treatment.
In contrast, memory CD4 + T cells behaved similarly in Ig-treated and nontreated mice over time as can be seen in Figure 3B (at 4 and after 8 wk: P = 0.74, and P = 0.72, respectively, Wilcoxon test), indicating that the Ig molecule may act differently upon naive or memory subpopulations. Possibly related to the predominance of naive compartment in the treated groups early after ASCT, there was a significant increase in the percentage of memory CD4 + T cells of the control group (at 2 wk after ASCT, P = 0.001, Wilcoxon test). At the end of follow-up, the percentages of memory T cells in both studied transplanted groups were well above the values observed in thymus-intact mice (P = 1.14e-9, Student t test).
These results suggest that Ig treatment may act as a stimulator of the maintenance of naive pool of T lymphocytes. As the transplant recipients were athymic in this model, we reason that Ig may act in this context, primarily by stimulating peripheral naive CD4+ T-cell survival and/ or proliferation.
As clear from the data shown above when treated with Ig, the lymphopenic state of athymic mice is significantly ameliorated. This improvement is seen not only by the expansion of memory T cells, as expected in a situation of recovery from a severe lymphopenia state, but also by an early expansion of the naive compartment. Ig effect may be related to the molecule ability to be recognized by other cells, as dendritic cells and T cells, inducing naive T cells to proliferate. A schematic representation of the dynamics of T-cell reconstitution under Ig-treatment can be seen in Discussion section, Figure 5 .
Analysis of Naive CD4 + T-cell Proliferation
Quantitation of sjTRECs was used as a molecular tool to assess the peripheral proliferation of naive T-cell compartment, as dilution of sjTRECs, in the absence of thymus, is directly correlated with peripheral T-cell proliferation 28 and the memory compartment of T cells contain a very low proportion of sjTRECs. 27, 34 SjTREC levels measured over time in athymic mice treated with Ig molecule or its fragments were compared with control mice injected with phosphate-buffered saline, after myeloablative therapy and ASCT.
Treated mice showed a relevant, 2.5-fold dilution of TRECs immediately after transplant and a significant difference between the groups was verified at 2 to 4 weeks (P = 0.03, Wilcoxon test) (Fig. 4A) . The slight increase of sjTRECs observed between the fourth and sixth weeks after transplant did not reach statistical significance (P = 0.47, Student t test) (Fig. 4A) .
In the Ig-treated group, an equilibrium was reached with a low level (median of 1003) of sjTRECs/10 5 PBMCs at 10 weeks after ASCT. This phenomenon was delayed in Our results in the control group indicated that at 12 weeks after thymectomy (10 wk after ASCT), sjTREC levels were greatly reduced in the periphery, probably because of both, homeostatic proliferation and the absence of thymus. For mice receiving Ig or its fragments, sjTRECs levels were persistently inferior at all time points. The early dilution of sjTRECs suggests a scenario of important peripheral T-cell proliferation, which is promoted by Ig treatment possibly through a variety of mechanisms related to molecular interaction between the Fab and Fc portions of the molecule and immune cells.
An independent analysis was designed to specifically test the effect of the Ig molecule fragments: Fab and Fc. Results in Figure 4 show that polyclonal Ig-treated and Fc-treated groups exhibited the greatest reduction in TREC levels. In the Fab-treated group, we also observed a 5-fold decrease in TREC levels compared with controls, but this difference did not reach statistical significance.
DISCUSSION
In this study, we show that treatment with polyclonal Ig is able to improve immune recovery after ASCT, reconstituting earlier and higher numbers of T cells. In addition, our results show that Ig predominantly promotes naive T-cell proliferation in situations of severe lymphopenia after myeloablative treatments.
The data presented here suggest that polyclonal Ig in physiologic serum concentrations acts as a self-antigenpromoting division and survival of naive T cells. Moreover, here we show that in situations of lymphopenia, which occur immediately after myeloablative treatments and stem cell transplantation, Ig treatment is capable of simultaneously allowing memory T-cell recovery and proliferation of phenotypically stable naive T cells. This may protect the diversity of the reconstituted repertoire. Although this beneficial effect may be transient, it occurs precisely during the initial phase after transplant, when T-cell immunity is most compromised. 3, 35 The mouse model presented here was set up to mimic the immunologic recovery occurring in adult patients with a hypothymic function subject to autologous hematopoietic transplantation. It allows testing of the effect of immunomodulatory molecules such as polyclonal Ig through the analysis of changes occurring at the peripheral T-cell compartment, namely T-cell responses to proliferative stimuli, T-cell memory generation, and homeostasis. The severely compromised thymic functions in these patients were mimicked in this study by thymectomy, which induces lymphopenia besides the occurrence of peripheral homeostatic proliferation as shown earlier in infants subjected to cardiac surgery. 36 In cases of severe lymphopenia, the homeostatic peripheral expansion mechanism is dominant toward the replenishment of the T-cell compartment through proliferative mechanisms. 3 In the athymic control group, we observed that lymphopenia recovers mainly through the expansion of the memory T-cell compartment, accompanied by a great reduction of the naive compartment. The lymphopenic state occurs, therefore, at the expense of the naive compartment. When treated with Ig, the lymphopenic state of athymic mice is significantly ameliorated not only by the expansion of the memory compartment, as expected, but also by an early expansion of the naive compartment. In the absence of a specific antigenic stimulation, lowaffinity interactions between self molecules such as Ig and TCR seem to be the major mechanism for cell survival and expansion of naive T cells in lymphopenia. 37, 38 The Ig-directed dynamics as shown above are schematically represented in Figure 5 .
Our results highlight the role of the Ig molecule as a unique self antigen able to promote survival and proliferation of naive CD4 T cells, when present at low concentrations. In this study, the circulating concentrations of Ig in the treated groups were never supra-physiologic and all mice recover some serum Ig during followup ( Justo L, Afonso AF, et al. Immunoglobulin treatment improves reconstitution of B cell compartment after autologous stem cell transplantation (ASCT) (in preparation). Our molecular data showing a significant decrease in the TREC content at periphery when mice were treated with polyclonal Ig or with the fragments of the molecule, suggest the Ig molecule to be a promoter of naive CD4 + T-cell proliferation while maintaining the phenotypic characteristics of this compartment. This effect is different from the known action of IL-7 promoting T-cell proliferation in the context of lymphopenia, in which IL-7 predominantly acts on CD8 + T cells. 5 The fact that control mice also show a significant decrease of TRECs after ASCT seems to be related to the lack of production of new T cells because of thymectomy together with the expected process of proliferation secondary to the lymphopenia. In fact, homeostasis was already evident 10 weeks after transplant.
Besides the controversy in the literature regarding the cost effectiveness of IvIg treatment in a situation of immune reconstitution, several reports have shown a clinical advantage for the use of IvIg after stem cell transplantation, with a confirmed decrease in the incidence of infections during the lymphopenic periods. 26, 39, 40 Added to this effect, the results presented here emphasize the central role of the Ig molecule as a self molecule directly or indirectly stimulating T cells.
Our results corroborate the existence of separate and independent mechanisms for naive and memory T-cell expansion and control. 2, 41 It is probably beneficial that independent regulatory mechanisms for naive and memory T-cell populations are engaged, as they may allow a simultaneous expansion of a diverse repertoire and maintenance of a large memory set of cells able to rapidly react against known antigens. We foresee that the injection of Ig will increase the availability of self peptides and therefore the frequency of low-affinity interactions, protecting the naive phenotype and preventing repertoire diversity contraction, which occurs during homeostatic peripheral proliferation. In addition, an optimal regulation of T-cell immunity under Ig treatment may protect against autoimmunity, a condition not evident in our study. There is also the possibility of an Ig-mediated activation of a specific subset of T cells, such as natural naive Tregs. Tregs are the T-cell subset known to be targeted by the Ig, being upregulated and functionally stimulated. 18, 23, 24 Moreover, dendritic cells and monocytes are very good candidates as the cell type under the direct influence of Ig resulting in the production of cytokines able to stimulate T cells.
The effect of the IvIg may remain beyond the half-life of the infused IgG and it may modify the cellular immune compartment for a prolonged period, perhaps in relation to the niche distribution equilibrium. Further, the mechanisms involving Fc and Fab moieties of Ig deserve additional investigation. Receptor candidates for Ig or its fragments may be either present on T cells allowing a direct action of the Ig molecules, and/or present on antigen-presenting cells, facilitating T-cell activation. Possible receptors may be involved in the identification of the network idiotype or anti-idiotype. In addition, molecules related to TCR and CD4 or even Fc receptors may be considered as possible recognition sites of Fab and Fc fragments, respectively.
Together, these mechanisms may prove to be essential in the maintenance of a naive population of T cells and of the diversity of the repertoire in the setting of lymphopenia and peripheral T-cell proliferation.
